Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|October 10, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patientsTamar Tadmor, Judit Demeter, Andrei Fagarasanu, et al.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Blood|June 30, 2021
The protein landscape of chronic lymphocytic leukemiaFabienne Meier-Abt, Junyan Lu, Ester Cannizzaro, et al.
Molecular Cancer|March 2, 2025
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemiaStephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
Frontiers in Oncology|February 15, 2021
The Effect of <i>SF3B1</i> Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in CancerAlexander C Leeksma, Ingrid A M Derks, M Haidar Kasem, et al.
Genome Medicine|March 20, 2020
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLLJustyna A Wierzbinska, Reka Toth, Naveed Ishaque, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|October 10, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patientsTamar Tadmor, Judit Demeter, Andrei Fagarasanu, et al.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Blood|June 30, 2021
The protein landscape of chronic lymphocytic leukemiaFabienne Meier-Abt, Junyan Lu, Ester Cannizzaro, et al.
Molecular Cancer|March 2, 2025
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemiaStephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
Frontiers in Oncology|February 15, 2021
The Effect of <i>SF3B1</i> Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in CancerAlexander C Leeksma, Ingrid A M Derks, M Haidar Kasem, et al.
Genome Medicine|March 20, 2020
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLLJustyna A Wierzbinska, Reka Toth, Naveed Ishaque, et al.
Pageof 19